@article{IR,
      author = {Greiling, Teri and Hajar, T. and Latour, E.J. and Haynes,  D. and Topham, C. and Hill, E. and Strunck, J. and Simpson,  E.L.},
      url = {http://digitalcollections.ohsu.edu/record/8336},
      title = {Low-dose methotrexate safety in dermatologic disease:  incidence and timing of laboratory abnormalities during the  first year of therapy},
      publisher = {Oregon Health and Science University},
      abstract = {Methotrexate is a commonly used medication for  inflammatory and autoimmune disorders. Dermatologic  literature recommends frequent laboratory monitoring due to  the potential of serious side effects although data  supporting this recommendation is lacking. In this study,  we aimed to identify the incidence and timing of laboratory  abnormalities in a cohort of patients prescribed low-dose  methotrexate during their first year of therapy.},
      number = {IR},
      doi = {https://doi.org/10.6083/cn69m494r},
      recid = {8336},
      address = {2020},
}